TCTR20160113001招募中3 期
Efficacy of itraconazole for invasive fungal infection prophylaxis after induction chemotherapy
siriraj oncology foundation0 个研究点目标入组 132 人开始时间: 2016年1月13日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 132
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •- age 15 year-old or older
- •- newly diagnosed or relapsed acute myeloid leukemia
- •- recieved induction chemotherapy treatment included 7+3 regimen, 5+2 regimen, MEC, FLAG, FLAG-ida or Clofarabine
- •- serum SGOT and SGPT not exceed 2-folds of upper normal limit
- •- creatnin clearance not lower than 50 mg/min
- •- informed consent
排除标准
- •- history of allergy to itraconazole
- •- pregnant
- •- recently diagnosed invasive fungal infection and recieved antifungal medications within 7 days
- •- indicated to recieved other definite antifungal treatment
- •- co-treatment with medications that have major drug interaction with itraconazole for examples: simvastatin, ergot alkaloids
研究者
相似试验
进行中（未招募）
4 期
A Study of Itraconazole in the Management of Superficial Fungal Infections in IndiaCTRI/2019/06/019547Johnson Johnson Private Limited
尚未招募
不适用
Study of 3 different dosages i.e Itraconazole 100mg vs 200mg vs 400mg or 5mg/kg whichever is lower in treatment of dermatophytosis (Ringworm)CTRI/2020/08/027063SOA university
已完成
不适用
A Study of Empirical Antifungal Therapy With ItraconazoleNeutropeniaNCT01706562Janssen Korea, Ltd., Korea138
尚未招募
3 期
Efficacy and safety of itraconazole, SUBA-itraconazole and voriconazole in Recalcitrant Dermatophytosis.CTRI/2024/05/066681I
已完成
4 期
Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal InfectionInvasive Fungal InfectionNCT01198236Zhejiang University150